Opinion

Jan 26, 2025, 14:04

5 Articles in Immunotherapy suggested by Wafik El-Deiry

Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.

Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.

Wafik El-Deiry

Wafik El-Deiry shared a few must-reads paper on X:

Imatinib and the dawn of precision cancer therapy

Author: Brian J. Druker

5 Articles in Immunotherapy suggested by Wafik El-Deiry

Novel treatment strategy targeting interleukin-6 induced by cancer associated fibroblasts for peritoneal metastasis of gastric cancer

Authors: Ema Mitsui et al.

Wafik El-Deiry

Systemic IFN-I combined with topical TLR7/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells

Authors: Martina Sanlorenzo et al.

5 Articles in Immunotherapy suggested by Wafik El-Deiry

Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial

Authors: Christian Kurzeder et al.

5 Articles in Immunotherapy suggested by Wafik El-Deiry

Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD

Authors: Mayra Shanley et al.

5 Articles in Immunotherapy suggested by Wafik El-Deiry

Abhinav Jain Agnes Csiszar Alexander Ring Alina D. Landau Ana Gvozdenovic Ana Karen. Nunez Cortes Andreas Wicki Angela Kohler Babak Monshi Bich Doan Nguyen-Sträuli Bilge V. Göcen-Oguz Bin Liu Brian J. Druker cancer Christian Kurzeder Christoph Rochlitz Corry M. Jones Cristiano De Sa Fernandes Cvetka Grašič Kuhar Denise Vorburger Donghai Xiong Elizabeth J. Shpall Ema Mitsui Enli Liu Fabienne D. Schwab Francesc Castro-Giner Frederick F. Lang Gabriela M. Kuster Gary M. Deyter Heike Frauchiger-Heuer Hila Shaim Hind Rafei Hiroshi Tazawa Igor Vujic Ilona Krol Isabell Witzel Jezreel Pantaleón García Jinzhuang Dou Joy Gumin Junko Ohtsuka Katayoun Rezvani Kazuhiro Noma Ken Chen Klemens Rappersberger Luis Muniz-Feliciano Manuel Nüesch Marcus Vetter Maren Vogel Maria Sibilia Martin Holcmann Martina Hammer Martina Sanlorenzo May Daher Mayra Shanley Merve Dede Mohammad Fayyad Zaman Nadima Uprety Natalie W. Fowlkes Nicola Aceto Noriyuki Nishiwaki OncoDaily Oncology Ourania Fari Patrick Zhang Philipp Novoszel Qi Miao Rafet Basar Rieko Ohki Samantha Claire Hicks Sanjay Singh Satoru Kikuchi Scott E. Evans Selina Budinjas Shan He Shinji Kuroda Shunsuke Kagawa Simran Asawa Sufang Li Sunil Acharya Tommaso Gastaldi Tomohiro Okura Toshiaki Ohara Toshiyoshi Fujiwara Vakul Mohanty Viola Heinzelmann-Schwarz Wafik El-Deiry Walter Paul Weber Ye Li Yu Wei Zhang Yuta Une

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC